Norihiro Kaneko

1.0k total citations
57 papers, 698 citations indexed

About

Norihiro Kaneko is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Norihiro Kaneko has authored 57 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Norihiro Kaneko's work include Pneumonia and Respiratory Infections (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Norihiro Kaneko is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Norihiro Kaneko collaborates with scholars based in Japan, United States and France. Norihiro Kaneko's co-authors include Yoshihiro Ohkuni, Katsutoshi Ando, Nobuhiro Asai, Kazuhisa Takahashi, Shinji Motojima, Fumiyuki Takahashi, Kei Nakashima, Tokuhide Doi, Masahiro Aoshima and Akihito Kubo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Norihiro Kaneko

51 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norihiro Kaneko Japan 12 256 210 188 169 126 57 698
Osamu Matsuno Japan 14 351 1.4× 127 0.6× 204 1.1× 113 0.7× 59 0.5× 49 681
Yutaka Hirasawa Japan 13 539 2.1× 136 0.6× 196 1.0× 106 0.6× 151 1.2× 27 874
Maija Halme Finland 20 467 1.8× 218 1.0× 197 1.0× 275 1.6× 89 0.7× 52 920
N. Freymond France 11 177 0.7× 88 0.4× 135 0.7× 155 0.9× 78 0.6× 45 576
Yu Hara Japan 13 315 1.2× 158 0.8× 72 0.4× 103 0.6× 110 0.9× 94 599
Meng Xia United States 18 877 3.4× 143 0.7× 273 1.5× 100 0.6× 181 1.4× 44 1.2k
Kenji Tsushima Japan 15 517 2.0× 205 1.0× 168 0.9× 50 0.3× 105 0.8× 52 853
Keishi Oda Japan 16 536 2.1× 139 0.7× 182 1.0× 51 0.3× 66 0.5× 36 701
J E Parrillo United States 11 114 0.4× 182 0.9× 85 0.5× 121 0.7× 88 0.7× 26 744
David Zhang United States 12 292 1.1× 95 0.5× 92 0.5× 50 0.3× 85 0.7× 30 567

Countries citing papers authored by Norihiro Kaneko

Since Specialization
Citations

This map shows the geographic impact of Norihiro Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiro Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiro Kaneko more than expected).

Fields of papers citing papers by Norihiro Kaneko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihiro Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiro Kaneko. The network helps show where Norihiro Kaneko may publish in the future.

Co-authorship network of co-authors of Norihiro Kaneko

This figure shows the co-authorship network connecting the top 25 collaborators of Norihiro Kaneko. A scholar is included among the top collaborators of Norihiro Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihiro Kaneko. Norihiro Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asai, Nobuhiro, Yoshihiro Ohkuni, Wataru Ohashi, & Norihiro Kaneko. (2023). Modified MRC assessment and FEV1.0 can predict frequent acute exacerbation of COPD: An observational prospective cohort study at a single-center in Japan. Respiratory Medicine. 212. 107218–107218. 4 indexed citations
2.
Suzuki, Motoi, Naoko Katsurada, Minh Nhat Le, et al.. (2018). Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan. Vaccine. 36(21). 2960–2967. 15 indexed citations
3.
Aoshima, Masahiro, Koya Ariyoshi, Norichika Asoh, et al.. (2014). The two years of prospective hospital based multicenter adult pneumonia surveillance in Japan; the final year report of APSG-Japan. European Respiratory Journal. 44(Suppl 58). P1054–P1054. 1 indexed citations
4.
Ando, Katsutoshi, Fumiyuki Takahashi, Motoyasu Kato, et al.. (2014). Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer. PLoS ONE. 9(7). e102436–e102436. 105 indexed citations
5.
Konno, Satoshi, Nobuyuki Hizawa, Hironi Makita, et al.. (2014). The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma. Pharmacogenetics and Genomics. 24(5). 246–255. 6 indexed citations
6.
Ando, Katsutoshi, Norihiro Kaneko, Tokuhide Doi, Masahiro Aoshima, & Kazuhisa Takahashi. (2014). Prevalence and risk factors of aortic aneurysm in patients with chronic obstructive pulmonary disease.. PubMed. 6(10). 1388–95. 10 indexed citations
7.
Asai, Nobuhiro, Yasutaka Kawamura, Yoshihiro Ohkuni, et al.. (2013). Is emphysema a risk factor for pneumothorax in CT-guided lung biopsy?. SpringerPlus. 2(1). 196–196. 38 indexed citations
8.
Asai, Nobuhiro, et al.. (2013). Therapeutic impact of CT-guided percutaneous catheter drainage in treatment of deep tissue abscesses. The Brazilian Journal of Infectious Diseases. 17(4). 483–486. 11 indexed citations
9.
Ando, Katsutoshi, Shinji Motojima, Tokuhide Doi, et al.. (2013). Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease. Respiratory Investigation. 51(2). 69–75. 27 indexed citations
10.
Asai, Nobuhiro, et al.. (2013). Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence. Jornal Brasileiro de Pneumologia. 39(2). 242–244. 4 indexed citations
11.
Asai, Nobuhiro, Yoshihiro Ohkuni, Ryo Matsunuma, et al.. (2012). Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy. Journal of Cancer Research and Therapeutics. 8(2). 266–266. 11 indexed citations
12.
13.
14.
Asai, Nobuhiro, Yoshihiro Ohkuni, Takuya Iwasaki, et al.. (2011). Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Journal of Infection and Chemotherapy. 17(6). 793–798. 7 indexed citations
15.
Ando, Katsutoshi, Yoshihiro Ohkuni, Hideki Makino, et al.. (2011). [Relationship between the prognosis of interstitial pneumonia and its comorbidities].. PubMed. 49(11). 800–9. 3 indexed citations
16.
Asai, Nobuhiro, Yoshihiro Ohkuni, Ryo Matsunuma, Yoshihito Otsuka, & Norihiro Kaneko. (2011). Radiological features of pneumocystis pneumonia (PCP) without HIV. European Respiratory Journal. 38(Suppl 55). p3669–p3669. 1 indexed citations
17.
Ando, Katsutoshi, Keiko Hasegawa, Yoshihiro Ohkuni, et al.. (2011). The Relationship Between The Prognosis Of Interstitial Pneumonia And Its Comorbidity. A1536–A1536. 1 indexed citations
18.
Ando, Katsutoshi, Yoshihiro Ohkuni, Hideki Makino, et al.. (2011). [A clinical review of pleurodesis for patients with poor performance status].. PubMed. 49(10). 723–8. 1 indexed citations
19.
Matsunuma, Ryo, et al.. (2010). Clinical Stage I Lung Cancer in an Aging Population. Haigan. 50(2). 115–121. 1 indexed citations
20.
Nakayama, Hideaki, Masato Shibuya, Norihiro Kaneko, et al.. (1998). Benefit of in‐phase chest wall vibration on the pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Respirology. 3(4). 235–240.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Osamu Matsuno Breakdown of academic impact, for papers by Yutaka Hirasawa Breakdown of academic impact, for papers by Maija Halme Breakdown of academic impact, for papers by N. Freymond Breakdown of academic impact, for papers by Yu Hara Breakdown of academic impact, for papers by Meng Xia Breakdown of academic impact, for papers by Kenji Tsushima Breakdown of academic impact, for papers by Keishi Oda Breakdown of academic impact, for papers by J E Parrillo Breakdown of academic impact, for papers by David Zhang
Rankless by CCL
2026